| CRUZ-SENIOR STUDY: FIRST PATIENT IN
First patient included in the CRUZ-SENIOR STUDY.
| CAN-SHOCK starts into the next phase!
Another important milestone has been achieved, allowing the Institute for Myocardial Infarction Research to generate new data to understand the efficacy and safety of cangrelor in high-risk patients.
| Interim Results COVID-19-Register RLP
Day-to-day research results on the COVID-19 situation in hospitals, based on our own COVID-19 registry.
| Renewed interim analysis of the COVID-19 registry provides important information on the situation in hospitals.
Presentation of the second evaluation of the COVID-19 registry for Rhineland-Palatinate by Dr. Anselm K. Gitt, board of directors of Foundation Institute for Myocardial Infarction Research in and study director of the COVID-19 registry...
| CAN-SHOCK gets off to a start
The ethics committee approved the observational monitoring design for the CAN-SHOCK registry with no further conditions.
| THANK YOU
"The future depends on what we do today." Mahatma Gandhi
| PRESS CONFERENCE OF IHF AND MINISTER OF HEALTH (RHINELAND-PALATINATE) ON COVID-19 REGISTRY
Minister Sabine Bätzing-Lichtenthäler of the Ministry of Social Affairs, Labour, Health and Demography (MSAGD) of the federal state of Rhineland-Palatinate and the Institute for Myocardial Infarction Research (IHF) presented first results of the...
| SET-UP OF CRUZ-SENIOR STUDY
The Institute for Myocardial Infarction Research (IHF) has started preparations for one of the largest coronary stent register.
| Important milestone reached in the study PASSPORT-HF
Recruitment for the PASSPORT-HF study conducted by IHF has started with the inclusion of the first patient!
| Dr. Andreas Schemenewitz new managing director of IHF GmbH
With Dr. Andreas Schemenewitz, the IHF GmbH gets an additional energetic contribution to expansion and strengthening of the market position as well as for the combination of scientific and medical competence and innovative, researching industrial...